)
ANI Pharmaceuticals (ANIP) investor relations material
ANI Pharmaceuticals AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
The meeting was called to order by the CEO, who welcomed attendees and outlined the rules of conduct for the virtual meeting.
The Inspector of Election was introduced and his oath was filed with the meeting minutes.
The agenda included director elections, ratification of the auditor, executive compensation, frequency of advisory votes, and an amended stock incentive plan.
Board and executive committee updates
Directors and executive officers were introduced, including the announcement of the retirement of the Chairman and the appointment of a new Chairman.
The current officers and the independent auditor from Ernst & Young LLP were introduced.
Shareholder proposals
Proposals included the election of directors, ratification of the auditor, approval of executive compensation, frequency of advisory votes, and approval of the amended stock incentive plan.
The board recommended voting in favor of all proposals.
- Rare disease and Generics growth to drive sales past $1 billion in 2026, led by Cortrophin Gel.ANIP
47th Annual Raymond James Institutional Investor Conference9 May 2026 - Q1 2026 revenue up 20.5%, net income doubled, and $100M share buyback approved.ANIP
Q1 20268 May 2026 - Record growth, robust governance, and expanded equity plan headline this year's proxy.ANIP
Proxy filing9 Apr 2026 - Virtual meeting to vote on directors, auditor, compensation, and stock plan updates.ANIP
Proxy filing9 Apr 2026 - Rare disease, ophthalmology drive double-digit growth; sales force expansion to fuel future gains.ANIP
Leerink Global Healthcare Conference 202619 Mar 2026 - Rare Disease portfolio drives robust growth, with Cortrophin and ILUVIEN poised for multi-year expansion.ANIP
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Rare Disease to drive 60% of 2026 revenue, with Cortrophin Gel fueling multi-year growth.ANIP
Corporate presentation3 Mar 2026 - Record revenue and EBITDA growth in 2025, with Rare Disease leading and strong 2026 outlook.ANIP
Q4 202527 Feb 2026 - ANI acquires Alimera for $381M, expanding rare disease and ophthalmology with strong synergies.ANIP
M&A Announcement3 Feb 2026
Next ANI Pharmaceuticals earnings date
Next ANI Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage